TrialBMC medicine2013

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.

Clifford J Bailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.